Boston Commerce Board of Directors

Get the latest insights into the leadership at Boston Commerce. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Ghanshyam Dhananjay Gavali Managing Director
Mr. Yash Arun Chaudhary Non Executive Director
Mr. Aashish Shrirang Dharmadhikari Independent Director
Mr. Swati Suresh Dhadve Independent Director

Boston Commerce Share price

BOSTONBIO

7.27

0.00 (0.00%)
Last updated on 4 Dec, 2025 | 15:15 IST
BUYSELL
Today's High

7.28

Today's Low

7.27

52 Week Low

6.53

52 Week High

22.00

The current prices are delayed, login to your account for live prices

Boston Commerce FAQs

The board at Boston Commerce consists of experienced professionals, including Mr. Ghanshyam Dhananjay Gavali , Mr. Yash Arun Chaudhary , and others, overseeing the company’s strategic and corporate governance.

Directors at Boston Commerce are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Ghanshyam Dhananjay Gavali is the current chairman at Boston Commerce.

Executive directors at Boston Commerce are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Boston Commerce adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Boston Commerce, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.